Business Overview
Sarah Cannon Research Institute
Advancing cancer therapies for patients.
Turning Today’s Clinical Trials Into Tomorrow’s Therapies
With 85% of people seeking cancer care in the community where they live, it’s important that every person facing cancer has access to the most advanced therapies through clinical trials without having to travel far from home.
Through Sarah Cannon Research Institute (SCRI), we are expanding access to potentially life-saving oncology therapies and clinical trial opportunities at the community level.
Our Focus Areas
We provide partners, physicians and patients access to:
End-to-end clinical trial site management and contract research services
A network of globally recognized cancer experts
Robust personalized medicine program, powered by Genospace
Discover Accelero™
Revolutionizing clinical trial delivery with Accelero™
Our accelerated operations model speeds up the clinical trial process so that researchers can focus on bringing cutting-edge cancer therapies to patients faster and more efficiently.
SCRI at a Glance
We support an expansive clinical research network.
1.3k+
There are more than 1,300 physicians participating in research across SCRI’s network.
~3.4k
Approximately 3,400 patients participate in our treatment trials each year.
850+
We have conducted more than 850 first-in-human trials to date.
200+
We have over 200 locations in more than 20 states.
Always Advancing
Today, one in two men and one in three women will be diagnosed with cancer during their lifetime. That’s why together with our partners, we offer research, insights, technologies and services that assist providers and biopharma companies in navigating the intricacies of advancing cancer care.
Advancing Precision and Personalized Medicine
Accelerating Care Through Our Oncology Ecosystem
Explore our SCRI Stories & Insights
Expanding Access to Cutting-Edge Clinical Trials in Community Oncology
Delivering on the Promise of Precision Medicine in the Community
Four Ways SCRI Supports Patients in Clinical Trials
Expanding Access to Quality Cancer Care
Advancing Precision and Personalized Medicine
A New Era in Cancer Care
Learn More About McKesson’s Solutions
Oncology & Multispecialty Solutions
Our focus is on collaborating with our partners and healthcare providers so that the latest advancements in cancer treatment reach those who need them most.
Learn more about McKesson’s oncology and specialty solutions that are accelerating specialized care.
Biopharma Capabilities
We are the only oncology research organization of its kind to offer end-to-end clinical trial site management, contract research services for biopharma and personalized medicine advisory services in one place.
Learn more about McKesson’s biopharma capabilities that are advancing healthcare forward.